Stryker Corporation
- SYK
- NYSE
- Medical devices
- Orthopedic Implants
- Joint Replacement
- Spine & Trauma Products
$298.00
Today +1.13%Quote Oct 19, 2026, 08:00 PM UTC
+5.19%over the last month
Max drawdown −3.7%From 1-month high 0.0%3 months −7.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Stryker
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries.
Where the money comes from
Q2 2026 revenue $6.59B
- MedSurg$3.63B55.0%
- Orthopaedics$2.96B45.0%
Sector
Healthcare
Industry
Medical devices
Exchange
NYSE
Employees
56,000
Dividend date
Oct 30, 2026
Market value
$114.30B
Quote Oct 19
Floor
$292.78
1.8% below price
Resistance
$299.48
0.5% above price
Price vs analyst targets
52 analysts
Lowest target
$310.00Highest target
$420.00
$310.00Highest target
$420.00
- Price $298.00
- Average target $365.89
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 23% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SYKPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free